Dr. Umar

This review synthesizes evidence that aflatoxins and fumonisins in staple foods drive major health risks, especially aflatoxin-related liver cancer amplified by HBV. It highlights biomarkers, mechanistic pathways, emerging non-cancer outcomes, and practical prevention strategies to reduce exposure globally.

This review links aflatoxin growth impairment through biomarker-supported evidence, especially in West African children during weaning. Dose–response associations with stunting and reduced height velocity suggest aflatoxin contributes to growth faltering, potentially via immune modulation and gut barrier disruption.

This mouse study evaluated acute safety of soluble allomelanin and engineered melanized E. coli Nissle. Neither caused weight loss or intestinal inflammation, and targeted microbial markers remained stable, while melanized E. coli Nissle rapidly colonized the gut within 3 hours and persisted for 24 hours.

Melanin is a family of biologic pigments with strong UV-absorbing and antioxidant properties. Humans use melanin for photoprotection, while many microbes use melanin to resist stress and enhance survival. In microbiome medicine, melanin can influence microbial resilience and host–microbe interactions.

This mouse study evaluated acute safety of soluble allomelanin and engineered melanized E. coli Nissle. Neither caused weight loss or intestinal inflammation, and targeted microbial markers remained stable, while melanized E. coli Nissle rapidly colonized the gut within 3 hours and persisted for 24 hours.

This review explains how bacteria produce melanin through DOPA, homogentisate (pyomelanin), and polyketide routes, how metals and stress regulators control pigmentation, and why melanins matter for virulence, persistence, and biotechnology.

This review explains how fungal melanin virulence in Cryptococcus neoformans enables immune evasion and persistence. In vivo melanization is supported by chemical markers, melanin-specific probes, and isolation of melanin “ghosts,” and melanization reduces susceptibility to oxidative killing and amphotericin B.

This study defines a nutrient-starvation–responsive network controlling cryptococcal melanin, centered on transcription factors Hob1, Bzp4, Usv101, and Mbs1 and upstream kinases Gsk3 and Kic1, converging on LAC1 laccase induction and pigment deposition programs.

This review explains how MC1R signaling controls eumelanin versus pheomelanin balance and how pheomelanin-biased pigmentation increases melanoma risk via oxidative stress and immune effects, including UV-independent mechanisms. No microbiome taxa or microbial pathways are reported.

This review connects microbial melanin and the microbiome to melanin’s structural diversity, measurement methods, and bioactivities. It highlights why accurate melanin classification matters and how microbial melanins may signal stress tolerance, persistence, and translational opportunities in antimicrobial and photothermal biomaterials.

Reactive oxygen species (ROS) are oxygen-based molecules that act in immune defense and cellular signaling. In the gut, epithelial and immune-cell ROS shape microbial ecology and barrier function. Excess ROS contributes to oxidative stress, inflammation, and permeability changes relevant to microbiome medicine.

This consensus statement provides reactive oxygen species measurement guidelines, emphasizing ROS chemical specificity, validated probes, orthogonal confirmation, and MS-based oxidative damage biomarkers. It warns against common artefacts (DCFH-DA, HE/MitoSOX fluorescence-only, TBARS) and stresses biomarker verification in clinical trials.

ROS in gastrointestinal inflammation are both antimicrobial signals and drivers of tissue injury. This review links NOX/DUOX and mitochondrial ROS to IBD, showing that low ROS (oxidase variants) and high ROS (dysfunction/upregulation) can each promote pathology, with microbiome ties such as Proteobacteria expansion.

In mice lacking epithelial NOX activity, the gut microbiome adapts by enriching H2O2-producing lactobacilli. This community suppresses Citrobacter rodentium virulence by downregulating LEE genes (ler/escN), conferring transmissible protection that is lost with antibiotics or Western diet.

This review explains how NOX1/DUOX2/NOX2-derived ROS—especially H₂O₂—act as microbiome-relevant signals that regulate pathogen virulence, commensal ecology, and mucosal repair, and why ROS deficiency (not just excess) can drive severe IBD phenotypes.

This review explains how free radicals drive health and disease through oxidative and reductive stress, detailing mitochondrial and hyperglycemia-linked sources and why many antioxidants fail clinically. It proposes cold atmospheric plasma as a tunable redox therapy for both degenerative and proliferative disorders.

This mini review reframes oxidative stress as a mechanistically grounded redox imbalance affecting signaling and damage, warns against nonspecific “ROS” language and total antioxidant capacity testing, and emphasizes enzymatic antioxidant defenses. It offers no direct microbiome signatures but clarifies host redox biology relevant to disease interpretation.

EDTA is a metal-binding compound used as a blood anticoagulant and food stabilizer. By binding calcium, it can influence intestinal barrier integrity, and EDTA-based permeability tests are used in gut research. Experimental data also link EDTA exposure to worsened colitis in models.

EDTA worsened colitis and increased colitis-associated tumors in two IBD mouse models, disrupted epithelial barrier integrity, reduced microbiome diversity, and enriched Akkermansia muciniphila and Peptostreptococcaceae—supporting EDTA as a diet-linked driver of inflammatory dysbiosis and carcinogenesis risk.

Intestinal permeability to [51Cr]EDTA in asymptomatic Crohn’s disease closely reflects subclinical inflammation. Elevated urinary excretion often occurred despite normal serum markers and low CDAI, and aligned with positive Indium-111 leukocyte scans, suggesting permeability is a sensitive indirect indicator of mild–moderate active disease.

In 52Cr-EDTA intestinal permeability in Crohns disease, urinary 52Cr-EDTA excretion correlated with fecal calprotectin and showed dysbiosis-consistent trends (lower F. prausnitzii, higher Enterobacteriaceae). This non-radioactive test may support noninvasive monitoring of subclinical activity and barrier-focused phenotyping.

EDTA increases intestinal permeability in rats, boosting absorption of neutral, basic, and acidic poorly absorbed compounds and increasing reverse flux of inulin into the lumen. Findings imply calcium-chelation loosens epithelial barriers, with implications for oral drug delivery and microbiome-related biomarker interpretation.

This review explains how tight junction proteins and signaling pathways control intestinal permeability and how cytokines, pathogens, and microbiome-derived metabolites (especially SCFAs) disrupt or restore the barrier, shaping inflammatory and systemic disease risk.

EDTA anticoagulant diagnostic sample stability is strongest for hematology, nucleic acids, and protease-labile peptides, but EDTA can cause platelet clumping/pseudothrombocytopenia, interfere with some cytokine and troponin assays, and confound electrolytes via chelation or contamination.